Analyst Research

Report Title Price
Provider: Stock Traders Daily
$20.00
Provider: New Constructs, LLC
$25.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Becton Dickinson And Co's BD PhaSeal System Receives Clearance From FDA Under Newly Created ONB Product Code


Tuesday, 15 Jan 2013 09:00am EST 

BD Medical, a segment of Becton Dickinson And Co, announced that the U.S. Food and Drug Administration (FDA) has cleared the BD PhaSeal Closed System Transfer Device (CSTD) under the newly created ONB code. The FDA clearance was based on three criteria: no escape of hazardous drug or vapor concentration, no transfer of environmental contaminants, and prevention of microbial ingress. The BD PhaSeal System is the only CSTD currently available that meets all three of these standards. 

Company Quote

118.22
0.32 +0.27%
19 Aug 2014